Ginsenoside Rg1 can prevent the increase in phosphorylation of FOXO1 in NAFLD, increase the levels of the antioxidant enzymes SOD and CAT, and maintain the activity of FOXO1 in the liver. Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.